Schonfeld Strategic Advisors’s Translational Development Acquisition Corp Warrants TDACW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.79K Hold
19,892
﹤0.01% 2137
2025
Q4
$5.87K Sell
19,892
-1,858
-9% -$609 ﹤0.01% 1970
2025
Q3
$6.31K Sell
21,750
-800
-4% -$217 ﹤0.01% 2136
2025
Q2
$6.56K Buy
22,550
+12,550
+126% +$2.59K ﹤0.01% 1959
2025
Q1
$2.55K Buy
+10,000
New +$1.76K ﹤0.01% 2147

Other funds holding TDACW

Schonfeld Strategic Advisors's TDACW Position: Q1 2026 in Review

Schonfeld Strategic Advisors held its Translational Development Acquisition Corp Warrants (TDACW) position steady in Q1 2026 at 19,892 shares worth $2.79K. The position accounts for ﹤0.01% of the portfolio, ranked #2137.

Schonfeld Strategic Advisors first reported a position in TDACW in Q1 2025 and has held it in 5 quarters since. The position peaked at $6.56K in Q2 2025. 32 funds tracked by Wall St. Rank hold TDACW as of Q1 2026.

  • Schonfeld Strategic Advisors held 19,892 shares of Translational Development Acquisition Corp Warrants worth $2.79K as of Q1 2026.
  • Schonfeld Strategic Advisors left its Translational Development Acquisition Corp Warrants share count unchanged in Q1 2026.
  • Translational Development Acquisition Corp Warrants made up ﹤0.01% of Schonfeld Strategic Advisors's portfolio in Q1 2026, its #2137 holding.
  • Schonfeld Strategic Advisors first reported a position in Translational Development Acquisition Corp Warrants in Q1 2025 and has held it in 5 quarters since.
  • Schonfeld Strategic Advisors's Translational Development Acquisition Corp Warrants position peaked at $6.56K in Q2 2025.
  • 32 funds tracked by Wall St. Rank held Translational Development Acquisition Corp Warrants as of Q1 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2026, filed 15 May 2026.